Antipsychotic medication and prefrontal cortex activation: A review of neuroimaging findings
- 30 June 2012
- journal article
- review article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 22 (6), 387-400
- https://doi.org/10.1016/j.euroneuro.2011.12.008
Abstract
No abstract availableThis publication has 97 references indexed in Scilit:
- Antipsychotic dose and diminished neural modulation: A multi-site fMRI studyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with SchizophreniaNeuropsychopharmacology, 2009
- FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophreniaSchizophrenia Research, 2009
- Changes in prefrontal and amygdala activity during olanzapine treatment in schizophreniaPsychiatry Research: Neuroimaging, 2009
- Dysregulation of working memory and default‐mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC studyHuman Brain Mapping, 2009
- Upcoming Agents for the Treatment of SchizophreniaDrugs, 2008
- Marked Hypofrontality in Clozapine-responsive PatientsPharmacopsychiatry, 2007
- Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophreniaSchizophrenia Research, 2005
- Functional and Anatomical Aspects of Prefrontal Pathology in SchizophreniaSchizophrenia Bulletin, 1997
- The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophreniaLife Sciences, 1988